Primary practice
Find Dr. Voglewede's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Voglewede practices at University Medical Center of El Paso in El Paso, Texas, part of El Paso County Hospital District.
Dr. Voglewede's NPI, 1588636633, was assigned on February 3, 2006. Dr. Voglewede graduated from Universidad Autonoma de Guadalajara in 1975. Dr. Voglewede holds Texas license G2504.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Voglewede's primary practice is University Medical Center of El Paso, at 4815 Alameda Ave, El Paso, TX 79905 in El Paso County. The practice phone is (915) 521-7602.
Source: Dmand AI Affiliation Data
Dr. Voglewede's primary practice is University Medical Center of El Paso in El Paso, Texas, part of El Paso County Hospital District. The medical group on file is Rio Grande Urology. Dmand AI also links Dr. Voglewede to 1 more group practice or clinic, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Voglewede practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University Medical Center of El Paso | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across El Paso County Hospital District and 6.2K+ hospitals, with verified contacts in the same login.
Urology is Dr. Voglewede's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Voglewede is board certified in urology by the American Board of Urology. Dmand AI has Dr. Voglewede's licenses on file in 3 states: Texas, Michigan and New Mexico.
Dmand AI lists enlarged prostate and prostate cancer among the conditions Dr. Voglewede treats.
Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 8,708 Medicare services from Dr. Voglewede across 6 procedure codes in 2023. Medicare paid $205,022 for them. Every service was in an office.
Medians across 809 urologists in Texas with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Voglewede?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Voglewede and other urologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Across all payers, Dmand AI patient panel data puts Dr. Voglewede's median patient age at 73, with 28% women.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 73
Source: Dmand AI Patient Panel Data
In 2024, Dr. Voglewede wrote 687 Medicare Part D claims for 112 patients. 19% of them were for generic drugs. CMS names the drug for 634 of them, across 8 drugs with 11 or more claims each, at $6,406,895 in total drug cost. In 2023, CMS named 1,386 claims across 13 drugs.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drugs named by CMS: 8 in 2024, 13 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Voglewede for performance year 2024, reported as part of a group.
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links Dr. Voglewede to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Color Vision Defects, Prostatic Neoplasms and Cone Dystrophy.
Conditions in Dr. Voglewede's trials
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
CMS Open Payments shows 735 general payments to Dr. Voglewede from 41 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 42% of the total. Janssen Pharmaceuticals, Inc paid the most, $37,628.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Voglewede graduated from Universidad Autonoma de Guadalajara in 1975.
Source: Dmand AI Professional Profile Data
Dr. Voglewede is in network with 19 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.
Source: Dmand AI Insurance Network Data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Daniel C. Voglewede's NPI number is 1588636633. It was assigned on February 3, 2006, and it is active in the NPI Registry.
Dr. Daniel C. Voglewede is a urologist in El Paso, Texas. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).
Dr. Voglewede practices at 4815 Alameda Ave, El Paso, TX 79905. Dr. Voglewede's primary practice is University Medical Center of El Paso in El Paso, Texas, part of El Paso County Hospital District. Dmand AI also links Dr. Voglewede to 1 group practice or clinic.
The practice phone on file for Dr. Voglewede is (915) 521-7602.
Dr. Voglewede holds Texas license G2504, one of the licenses on file in 3 states.
Dmand AI has state licenses on file for Dr. Voglewede in Texas (1982 to 2026), Michigan (1978 to 2012) and New Mexico (1979 to 2010).
Dr. Voglewede practices at University Medical Center of El Paso in El Paso, Texas.
Dr. Voglewede is linked to Rio Grande Urology.
Yes. CMS data shows Dr. Voglewede billed Medicare for 8,708 services in 2023.
Dr. Voglewede's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
Yes. Dr. Voglewede is board certified in urology by the American Board of Urology.
In 2023, Dr. Voglewede's most billed Medicare services were injected or infused drug (J0897), injected or infused drug (J9217) and office visit, established patient (99215).
Dr. Voglewede graduated from Universidad Autonoma de Guadalajara in 1975.
In 2024 Medicare Part D data, Dr. Voglewede's most prescribed drugs by claims were Erleada, Xtandi and Orgovyx.
CMS Open Payments shows $145,981 in general payments to Dr. Voglewede from 41 companies from 2016 to 2024. The largest total came from Janssen Pharmaceuticals, Inc.
Dr. Voglewede graduated from medical school in 1975, 51 years ago.
Dr. Voglewede has worked on 2 clinical trials.
Dr. Voglewede is in network with 19 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.
Selling to urology practices?
See urologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.